Header Logo

Siphamandla Gumede

Concepts (63)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medication Adherence
4
2024
151
2.340
 Why?
Viral Load
3
2022
819
1.240
 Why?
HIV Infections
6
2024
5097
0.960
 Why?
Anti-HIV Agents
2
2023
1324
0.880
 Why?
Anti-Retroviral Agents
2
2023
551
0.720
 Why?
Patient Acceptance of Health Care
2
2025
256
0.680
 Why?
Urban Population
2
2021
257
0.650
 Why?
HIV Protease Inhibitors
1
2019
92
0.640
 Why?
HIV
1
2021
380
0.640
 Why?
Stillbirth
1
2017
83
0.550
 Why?
Premature Birth
1
2017
80
0.520
 Why?
Prenatal Care
1
2017
147
0.520
 Why?
Retrospective Studies
3
2022
799
0.450
 Why?
Male
5
2025
6754
0.370
 Why?
Humans
7
2025
14537
0.370
 Why?
Female
5
2023
9103
0.350
 Why?
Cohort Studies
2
2023
967
0.340
 Why?
Adult
4
2023
5913
0.330
 Why?
CD4 Lymphocyte Count
2
2022
656
0.310
 Why?
Rural Population
2
2023
654
0.300
 Why?
South Africa
4
2023
7596
0.300
 Why?
Chronic Disease
1
2024
107
0.220
 Why?
Treatment Adherence and Compliance
1
2023
9
0.220
 Why?
Africa South of the Sahara
1
2024
353
0.210
 Why?
Young Adult
2
2021
2498
0.210
 Why?
Middle Aged
2
2021
3601
0.200
 Why?
Adolescent
2
2021
2985
0.200
 Why?
Health Services Accessibility
1
2025
280
0.200
 Why?
Clinical Trials, Phase IV as Topic
1
2021
1
0.200
 Why?
Clinical Trials, Phase I as Topic
1
2021
3
0.200
 Why?
Clinical Trials, Phase II as Topic
1
2021
10
0.200
 Why?
Clinical Trials, Phase III as Topic
1
2021
20
0.200
 Why?
Randomized Controlled Trials as Topic
1
2021
244
0.180
 Why?
Aged, 80 and over
1
2021
468
0.170
 Why?
Retreatment
1
2019
6
0.170
 Why?
Databases, Factual
1
2019
64
0.170
 Why?
Zidovudine
1
2019
59
0.170
 Why?
Lamivudine
1
2019
89
0.160
 Why?
Lost to Follow-Up
1
2019
62
0.160
 Why?
Treatment Failure
1
2019
175
0.160
 Why?
Lopinavir
1
2019
137
0.160
 Why?
World Health Organization
1
2019
137
0.160
 Why?
Ritonavir
1
2019
137
0.160
 Why?
Reverse Transcriptase Inhibitors
1
2019
118
0.160
 Why?
Drug Therapy, Combination
1
2019
279
0.160
 Why?
Sex Factors
1
2019
227
0.160
 Why?
Tenofovir
1
2019
171
0.160
 Why?
Age Factors
1
2019
370
0.150
 Why?
Vulnerable Populations
1
2017
30
0.140
 Why?
Residence Characteristics
1
2017
57
0.140
 Why?
Odds Ratio
1
2017
133
0.140
 Why?
Transients and Migrants
1
2017
39
0.140
 Why?
Aged
1
2021
1740
0.140
 Why?
Pregnancy Outcome
1
2017
117
0.140
 Why?
Ambulatory Care Facilities
1
2017
125
0.140
 Why?
Logistic Models
1
2017
254
0.130
 Why?
Cesarean Section
1
2017
87
0.130
 Why?
Primary Health Care
1
2017
240
0.120
 Why?
Pregnancy Complications, Infectious
1
2017
529
0.100
 Why?
Pregnancy
1
2017
1862
0.090
 Why?
Child
1
2017
2242
0.090
 Why?
Men's Health
1
2025
3
0.060
 Why?
Africa
1
2025
376
0.050
 Why?
Gumede's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_